Wakefit Innovations Limited has announced a key senior management appointment, naming Mr. Nitesh Prakash as Senior Vice President – Home Interiors, effective March 30, 2026. The appointment was approved by the company's Board of Directors following a recommendation from the Nomination and Remuneration Committee.

Appointment Details

The company disclosed the appointment under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015. Mr. Prakash has been categorized as Senior Management Personnel and assumes his role with immediate effect.

Professional Background

Mr. Nitesh Prakash brings extensive experience as a seasoned operations leader, entrepreneur, and business builder with over a decade of experience spanning mobility, consumer brands, and large-scale operations. He is an alumnus of IIT Bombay, holding both B.Tech and M.Tech degrees in Chemical Engineering.

Career Highlights

Mr. Prakash's professional journey includes several notable positions:

• VP – Operations at Ola Electric: Led large-scale business expansion and operational initiatives
• Senior Director at Ola (ANI Technologies Pvt. Ltd): Managed operational turnaround and strategic initiatives across India
• Founder of O' Be Cocktails: Successfully scaled the venture into a multi-market brand with strong retail presence and secured funding support
• Previous roles: Experience with Foodpanda India and Procter & Gamble

Strategic Significance

The appointment demonstrates Wakefit Innovations' focus on strengthening its home interiors segment with experienced leadership. Mr. Prakash's track record includes scaling businesses, driving profitability, and building high-performance teams, which aligns with the company's growth objectives in the home interiors space.

Regulatory Compliance

The company has fulfilled all disclosure requirements under SEBI regulations, with the information made available on Wakefit's investor relations website. The appointment follows proper corporate governance procedures, including approval from the Nomination and Remuneration Committee and subsequent Board ratification.

Wakefit Innovations Limited has announced the approval of 1,72,762 employee stock options under its WAKEFIT ESOP-2019 plan. The company's Nomination and Remuneration Committee (NRC) passed the resolution on March 27, 2026, in compliance with SEBI regulations for share-based employee benefits.

ESOP Grant Details

The stock option grant represents a significant employee incentive initiative by the sleep and home solutions company. The options are structured to align employee interests with long-term company performance and retention objectives.

Vesting and Exercise Framework

The employee stock options follow a structured vesting and exercise timeline designed to encourage long-term employee commitment. The vesting schedule incorporates both time-based and performance-based criteria, subject to continued employment with the company.

Key Vesting Terms:

• Minimum vesting period: 12 months from grant date
• Maximum vesting period: 5 years from grant date
• Exercise window: 1 year from respective vesting date
• Vesting criteria: Time and/or performance-based as per Letter of Grant
• Employment requirement: Continued employment necessary for vesting

Regulatory Compliance and Documentation

The ESOP grant aligns with the Securities and Exchange Board of India (Share Based Employee Benefits & Sweat Equity) Regulations, 2021. Wakefit Innovations has fulfilled all disclosure requirements under Regulation 30 of the SEBI Listing Regulations, ensuring transparency for stakeholders.

The company filed the necessary documentation with both BSE Limited and National Stock Exchange of India Limited. Company Secretary and Compliance Officer Surbhi Sharma signed the regulatory filing, confirming adherence to all applicable guidelines and circular requirements.

Share Conversion Structure

Each granted option provides the right to acquire one equity share of Wakefit Innovations Limited upon exercise. The total potential dilution represents 1,72,762 equity shares, each carrying a face value of Re. 1. The exercise price of Re. 1 per option matches the face value of the underlying equity shares.

The company has made detailed information regarding this ESOP grant available on its investor relations website, ensuring accessibility for all stakeholders and maintaining transparency in its employee compensation practices.